Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Longer may speed healing by damaging both strands of bacterial genetic material

In a with a , later may shorten by pairing damage across bacterial strands. Reject this mechanism if predicts nothing after accounting for .

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Ageing mechanism

Main connectionGenomic instability

Direction

A double ring marks the main placement where a group contains several values.

Lens
Microbial dna repair failure
Goal
Согласование сроков защиты, заживления и возврата к нагрузке
Competing hypotheses
2
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
5 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
6 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research
Poster: Inflammation damages bacterial DNA
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Immune response

    The process through which comes to an end

    Where this hypothesis actsIn a containing viable microorganisms, with microbial burden and controlled

    Hypotheses on this target 4
    Inflammation resolutionInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 11Function preservation. Hypotheses on this target 0Clearance restoration. Hypotheses on this target 0Immunosuppression. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 11Rhythm restoration. Hypotheses on this target 11
    • Inhibition1
    • Activation1
    • Function preservation
    • Clearance restoration
    • Immunosuppression
    • Feedback restoration1
    • Rhythm restoration1

    What is proposed

    Inhibition

    Delay the completion of

    With whatNot stated in the record

    HowExtend oxidative exposure to promote spatially coincident damage to both bacterial strands; the intervention used to delay resolution is not stated

    Possible result

    Possible shorter time through prevention of renewed bacterial growth and recurrent

    From the recordПозднее завершение воспаления сокращает функциональное заживление, предотвращая повторную инфекционную волну.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionInflammation resolution. Hypotheses on this target 4Inflammation resolution
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin recovery depends on how soon repaired skin can withstand use without infection returning. The unexpected move is to make the location of damage inside surviving bacteria matter more than simply how many bacteria remain. This is a pipeline-generated proposal: extending , the body's local defense and injury response, might shorten total recovery by leaving bacteria unable to produce descendants.

The proposed mechanism, link by link
  1. Longer extends bacterial exposure to chemically reactive oxygen-containing substances.
  2. That exposure is proposed to accumulate damage at matching locations on opposite strands.
  3. Damage to both local records removes the intact local pattern that could otherwise guide repair.
  4. Some bacteria are proposed to shift from alive and able to recover to alive for now but likely to lose during repair.
  5. Fewer surviving bacteria produce descendants, preventing a renewed infection.
  6. Avoiding renewed infection is predicted to shorten the time until repaired skin withstands use.
A picture for it

Two copies of a page can help restore missing words, provided the same words are not missing from both. The same number of missing words becomes harder to recover when the gaps line up.

Where the picture breaks: strands are complementary records rather than identical pages. Bacteria may have additional copies of their genetic information or that do not require the intact opposite strand, and a damaged location need not prevent reproduction.

  1. Master questionstep 01 of 04

    A treatment is sought that would bring the functional condition of middle-aged people's skin closer to that of young people's skin.

    Rests on: The supplied goal identifies the population and desired comparison, but does not specify which skin functions would establish success.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Protection, wound healing and return to physical use should be timed together.

    Rests on: Coordinating recovery after injury is selected as a route toward younger-like skin function.

    Assumption

    The goal does not establish that coordinating wound recovery would restore the broader functional condition of middle-aged skin. That connection is taken as given.

  3. Gap questionstep 03 of 04

    Ending later might shorten the total time until skin works reliably again, if the stopping point depends on remaining microbes and the maturity of the , the supporting material surrounding tissue cells.

    Rests on: The preceding stage calls for coordinating protection, healing and return to use. This question makes that timing problem concrete by proposing conditions for ending .

    Stated in the chain
  4. Hypothesisstep 04 of 04

    Longer exposure to chemically reactive oxygen-containing substances is proposed to damage matching locations on both strands of bacterial . The proposed change is from bacteria that remain alive and can recover to bacteria that remain alive for now but are likely to lose the ability to reproduce when they attempt , the restoration of damaged genetic material. Preventing their return is then predicted to shorten recovery.

    Rests on: The preceding question makes remaining microbes a condition for ending . The endpoint supplies its own proposed explanation: two matching records can lose recoverable information when both are damaged at the same location, even if the total damage is unchanged.

    Stated in the chain

What is carried, and what is not. Individual background links have some support: Biomolecules (2024, S2) describes wound microbes being cleared by , a type of immune cell, but does not establish paired bacterial damage or a benefit from extending . None of the supplied source excerpts establishes the proposed sequence end to end; MedComm (2025, S5) reports a treatment that reduced late and improved diabetic wound healing, which challenges a general benefit from delay but does not test the proposed damage-location mechanism.S2S5

Where the reasoning is carried by something unstated · 1
  • Goal pillar. The goal does not establish that coordinating wound recovery would restore the broader functional condition of middle-aged skin. That connection is taken as given.
How a result here could mislead · 3
  • An apparent effect of damage location could reflect fewer bacteria capable of reproducing, or more total damage. Calling bacteria alive using the same reproductive outcome the hypothesis seeks to predict would also blur the proposed distinction between present survival and future . What closes it: The proposed comparison requires equal current numbers of living bacteria, equal total damage and equal . The test must define present survival separately from subsequent production of descendants, measure damage on opposite strands together, and specify how any added predictive value of damage location will be assessed.
  • A benefit from delaying the end of could arise because the early intervention disables , or because the delay improves tissue attachment. Either result could be credited incorrectly to bacterial damage. What closes it: Comparisons must distinguish suppressing immune defense from ending while preserving , and must measure tissue attachment as well as . Samples without microbes are required by the prediction that this mechanism's benefit disappears when microbes are absent; alone must not be presumed to capture every difference in tissue attachment.
  • Failure to prevent could be read as disproving the proposed damage mechanism even if the treatment never produced damage at matching locations. Conversely, an association between and poor would not by itself establish that repair caused irreversible loss of reproductive ability. What closes it: The test must verify directly and follow subsequent reproduction. The supplied specification also requires accounting for extra copies of bacterial genetic information and alternative ; it does not provide a method for isolating the claimed role of repair.

What would make this wrong. The supplied rejection criterion is that differences in are explained only by the number of living bacteria, with damage location adding no predictive information after that number is accounted for. More broadly, if verified fails to predict loss of reproduction and prevention of renewed under the proposed matched conditions, the claimed sequence is not supported. Even prevention of would leave the final link unestablished if it did not shorten functional recovery; the input provides no operational definition of that recovery endpoint.

What it would change. If the mechanism held, the condition of surviving bacteria would become relevant to choosing when should end: equal numbers of living bacteria would not necessarily mean equal risk of infection returning. Work toward restoring younger-like skin function would have a reason to consider future alongside tissue readiness for use. A result in the proposed outside the body, using a not expected to cause disease, would still not establish an effective treatment for middle-aged people, a suitable duration of , or restoration of skin function beyond wound recovery.

Sources read · 6

4 literature searches, 7 full texts, 3 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

Transcription-replication collisions trigger high-fidelity replication reset. · Nucleic acids research · 2025

“Factors that may contribute to this replication stress include reactive oxygen species, topoisomerase malfunction, the formation of RNA–DNA hybrids, and transcription–replication collisions (TRCs) [ ].”

Does not settle: This source does not establish inflammation duration, oxidative double-strand damage, bacterial regrowth risk, healing outcomes, reinfection, or SPV_5.

S2Background

How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation. · Biomolecules · 2024

“During wound healing, neutrophils clear pathogens and debris from the wound site, initiating the healing process and signaling other immune cells to aid in repair”

Does not settle: This source does not establish bacterial DNA double-strand damage, its accumulation during prolonged inflammation, bacterial repair or regrowth risk, recurrent infection, functional healing, or SPV_5.

S3Background

Life without dUTPase. · Frontiers in microbiology · 2016

“As heavily uracilated DNA may be degraded by uracil-DNA repair, the presence of these genes on mobile genetic elements suggests that damaging uracil-DNA repair might negatively influences their horizontal gene transfer”

Does not settle: Источник не устанавливает влияние длительности воспаления или окислительного воздействия на повреждения обеих цепей бактериальной ДНК, возобновление роста микроорганизмов, риск повторной инфекции или функциональное заживление.

S5Contradicts it

Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities. · MedComm · 2025

“Inhibition of JMJD3 in macrophages has been shown to reduce late‐stage inflammation and improve wound healing [ , ].”

Does not settle: Источник не устанавливает влияние воспаления на повреждения обеих цепей бактериальной ДНК, последующую репарацию, возобновление роста микроорганизмов, микробную нагрузку или SPV_5.

S6BackgroundAbstract only

GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing. · The Journal of investigative dermatology · 2025

“Diabetic foot ulcers (DFUs) represent a clinically burdensome and pathophysiologically distinct complication of diabetes mellitus, marked by persistent inflammation, dysregulated immune signaling, impaired angiogenesis, and delayed re-epithelialization.”

Does not settle: This abstract does not establish whether prolonged inflammation causes spatially coincident double-strand bacterial DNA damage, prevents bacterial regrowth or recurrent infection, or improves functional wound healing.

S7BackgroundAbstract only

Efficacy of Wound Cleansers on Wound-Specific Organisms Using In Vitro and Ex Vivo Biofilm Models. · Wound management & prevention · 2020

“Biofilms are believed to be a source of chronic inflammation in non-healing wounds.”

Does not settle: Источник не устанавливает, что более позднее завершение воспаления ускоряет функциональное заживление. Он не исследует сочетанные повреждения двух цепей бактериальной ДНК, последующую репарацию, риск возобновления роста при одинаковой микробной нагрузке или SPV_5.

The gap this hypothesis explains

Can ending later restore skin function sooner when timing follows remaining microbes and tissue framework maturity?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Может ли более позднее сокращать общее время , если момент переключения определяется и ?

What this question is asking

The question concerns whether that ends later could nevertheless allow damaged skin to regain its function sooner. It asks about choosing when ends according to the amount of microbes still present and how far the tissue’s supporting framework has developed. The relevant comparison is earlier versus later completion of , measuring the total time until function returns rather than simply whether new tissue forms. The question assumes that these two conditions can determine a meaningful switching point, but the supplied sources do not establish that assumption. Its stated context is middle-aged human skin, although restoring youthful skin function is not established as equivalent to healing a wound.

What the terms mean
Inflammation
The body’s response to injury or harmful material. The question concerns how long this response continues during repair.
Inflammation resolution
The process through which subsides and ends. Calling this a switch is a simplification; the supplied sources do not establish one discrete switching event.
Residual microbial burden
The amount of microbes, meaning microscopic organisms, remaining in the affected tissue. Bacteria are one group of microbes; the supplied evidence provides no measurement or cutoff for using their remaining amount to determine timing.
Matrix maturity
How far the material surrounding and supporting tissue cells has developed into its repaired state. Maturity describes a degree of development, not an established yes-or-no condition, and the supplied material does not define how to measure it.
Functional recovery or functional healing
Recovery of the tissue’s ability to perform its functions. This differs from observing new tissue formation, and the question does not specify which skin function must return.
Functional endpoint
The specified functional result used to decide that recovery has occurred. Total recovery time cannot be interpreted consistently without defining this result.
Tissue regeneration
Formation or restoration of tissue during repair. Reports of faster regeneration do not by themselves establish faster recovery of function.
Endotoxin
A component of certain bacteria that can trigger . S6 states that it can impair wound healing; its presence is not itself a measure of how many microbes remain.
Clearance of dying cells
Removal of cells undergoing a controlled process of death. S1 connects this process with heart wound healing and .
Experimental model
A studied system used to examine an injury or repair process. Findings in mouse liver injury or rat skin wounds do not establish the same result in middle-aged human skin.
What the question takes for granted
Premise not found in what was read
The switching time for ending is determined by and .

means the amount of microbes remaining in the affected tissue, while describes how far the material supporting its cells has developed. The question assumes that these two conditions can specify when should end. If established, that rule would distinguish a delay tied to tissue conditions from that merely persists.

The supplied sources do not establish a switching rule based on either condition, individually or together. S4 reports microbial defense, and tissue regeneration occurring with treatment, but does not describe using microbial burden or to choose timing. S7 connects bacterial interference with prolonged , which supports relevance of microbes but does not establish the proposed rule. This absence from the supplied evidence does not show that the rule is false.S4S7

The same question asked without the part nothing read establishes:

  • Does ending later rather than earlier shorten the time for skin function to recover at comparable levels of remaining microbes and tissue framework maturity?
  • Does ending later rather than earlier shorten the total time for skin function to recover?
What turns on the answer
  • Later completion shortens recovery Under the question’s proposed rule, would end later, yet skin would reach the same functional endpoint sooner. This would mean that time spent before ends cannot by itself indicate the total recovery time; the supplied evidence does not establish the intervening mechanism.
  • Later completion lengthens recovery Under the proposed rule, delaying ’s end would also delay the return of skin function. Treating that delay as beneficial would therefore prolong the outcome the rule was intended to shorten.
  • Later completion leaves recovery unchanged would end at different times, but skin would reach the same functional endpoint at the same time. Changing this timing would then provide no demonstrated reduction in overall recovery time under the compared conditions.
Why it matters

The proposed sequence connects remaining microbes and tissue framework maturity to the timing of ’s end, and that timing to the duration of functional recovery. The supplied literature reports that bacteria can interfere with repair by prolonging , while another source links clearance of dying cells to ending and heart function recovering (S7, S1). These findings make the reason persists relevant to interpreting its duration; that connection is an inference, not a tested timing rule. Assuming that a longer inflammatory period helps could mistake an obstacle to healing for a useful delay. Assuming that faster tissue formation proves faster functional recovery could also assign a benefit that the supplied evidence has not measured.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Польза более позднего определяется накоплением . При повреждении одной цепи другая может служить ; пространственно совпадающие повреждения обеих цепей лишают локальный участок этой возможности. Продлённое переводит часть ещё жизнеспособных микроорганизмов в состояние с высокой вероятностью необратимого повреждения при последующей . Поэтому одинаковая текущая может сопровождаться разным риском . Позднее сокращает , предотвращая повторную инфекционную волну. Физический носитель состояния представляет собой расположение повреждений в бактериальной ; предотвращение стабилизирует SPV_5.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

: . После учёта две цепи рассматриваются как две записи одного . X1 и X2 равны 1, если соответствующая цепь перестала быть пригодной этого , и 0 в противном случае. При одинаковой вероятности e = P(X1 = 1) = P(X2 = 1) и ρ между X1 и X2 вероятность потери обеих записей составляет P_fail = e² + ρe(1 − e). Для N вероятность хотя бы одной такой потери равна 1 − (1 − P_fail)^N. Здесь N обозначает число исследуемых , потеря которых критична для размножения бактерии. Это точная при названных допущениях; её соответствие проверяется экспериментально. Повреждения с ошибочным прочтением, дополнительные копии и восстановление без требуют расширения модели. Основание переноса: пределы восстановления записи при , сформулированные в [работе Шеннона](https://www.princeton.edu/~wbialek/rome/refs/shannon_48.pdf).

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковых , общем количестве повреждений и позднее даст преимущество преимущественно в образцах с большим числом . Их частота должна предсказывать утрату способности отдельных бактерий давать потомство и последующее отсутствие лучше, чем суммарное . В преимущество исчезнет. Если различия определяются только , а после учёта этого числа ничего не предсказывает, предложенный механизм отвергается.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies a comparative predictive outcome, disappearance of the advantage under sterile conditions, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Первичная проверка возможна в с подходящим . Совместная оценка повреждений противоположных цепей технически сложнее обычного измерения . Необходимо учитывать альтернативные способы и : они могут сделать двухкопийную модель неприменимой.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковых , общем количестве повреждений и позднее даст преимущество преимущественно в образцах с большим числом . Их частота должна предсказывать утрату способности отдельных бактерий давать потомство и последующее отсутствие лучше, чем суммарное . В преимущество исчезнет. Если различия определяются только , а после учёта этого числа ничего не предсказывает, предложенный механизм отвергается.

  • What would separate them

    Neutrophil myeloperoxidase may strengthen healing skin by crosslinking new basement membrane predicts: В стерильной с недостаточным поздняя увеличит количество и сократит время до . Выключение устранит этот выигрыш при сохранённых числе , и длительности . Решающий результат: сборки новой воспроизведёт образование под действием , а полученная мембрана после удаления улучшит механическое закрепление . Если образует только или рост их количества не улучшает функциональное восстановление, гипотеза отвергается.

  • What would separate them

    Conflating immune suppression with active resolution may explain an apparent benefit of delay predicts: В раннего и позднего начала двух типов вмешательства преимущество позднего срока обнаружится для подавления , но исчезнет для , сохраняющего . При сопоставимых исходной , длительности и фактическом раннее обеспечит такое же или меньшее время до одновременного , устойчивости к нагрузке и . Наличие воспроизводимого преимущества позднего срока при сохранённых защитных функциях опровергнет эту гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

6 papers retrieved around this hypothesis
  • Searching for sequence features that control DNA cyclizability.PMID 42255020 · full_text · 51,132 characters stored
  • Scale invariance in early embryonic development.PMID 39514304 · full_text · 70,592 characters stored
  • Deriving a genetic regulatory network from an optimization principle.PMID 39752518 · full_text · 74,897 characters stored
  • Trading bits in the readout from a genetic network.PMID 34772813 · full_text · 4,103 characters stored
  • On the dimensionality of behavior.PMID 35486689 · full_text · 51,369 characters stored
  • 30th Annual Computational Neuroscience Meeting: CNS*2021-Meeting Abstracts.PMID 34931275 · full_text · 831,020 characters stored

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.